3-D Matrix, Ltd. (DMTRF)

Market Cap	356.12M +285.6%
Revenue (ttm)	59.75M +38.4%
Net Income	8.07M
EPS	0.06
Shares Out	n/a
PE Ratio	44.11
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Open	1.110
Previous Close	2.250
Day's Range	1.110 - 2.250
52-Week Range	1.500 - 3.960
Beta	0.97
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 11, 2026

About 3-D Matrix

3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 114
• Stock Exchange: OTCMKTS
• Ticker Symbol: DMTRF

Financial Performance

In fiscal year 2025, 3-D Matrix's revenue was 6.93 billion, an increase of 51.13% compared to the previous year's 4.59 billion. Losses were -2.50 billion, 880.8% more than in 2024.

Financial numbers in JPY